Intriguingly, a mitochondrial targeted ceramide analogue effectively suppressed FLT3 inhibitor resistant AML patient samples in vivo39 suggesting the reactivation of mitochondrial ceramide synthesis downstream of FLT3 signalling may be beneficial in overriding FLT3 resistance. The gene discussed is FLT3; the disease is acute myeloid leukemia.